
UC Davis Clinical Trial Identifies Biomarkers Key to Treating Aggressive Prostate Cancer
In the realm of prostate cancer research, a groundbreaking Phase 2 clinical trial conducted at the University of California, Davis Comprehensive Cancer Center has unveiled insights that may reshape therapeutic strategies for men battling aggressive forms …